Investigating ioflupane I-123 injection and single photon emission tomography as an imaging biomarker for long-term sequelae following mild traumatic brain injury

摘要

Objective: To determine whether there were differences in clinical outcomes for ioflupane I-123 injection (DaTscan) and single photon emission tomography consistent with early Parkinson's disease (PD) among individuals with a history of mild traumatic brain injury (mTBI).